BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

Kuwait Medical Journal is a prominent scholarly publication dedicated to advancing medical knowledge and practice in the Gulf region and beyond. Published by the Kuwait Medical Association, this journal has been a crucial platform for disseminating research findings since its inception in 1973. Despite its discontinuation in Scopus coverage after 1990, it remains significant within the Q4 category in Medicine (miscellaneous), serving as a valuable resource for healthcare professionals, researchers, and students alike. The journal is based in Kuwait and aims to foster academic dialogue by featuring original research articles, reviews, and case studies that highlight the evolving landscape of medical science and practice. While currently not an open-access platform, the Kuwait Medical Journal continues to uphold the integrity and quality of medical research, contributing to the broader discourse in healthcare.

The Ibnosina Journal of Medicine and Biomedical Sciences, published by THIEME MEDICAL PUBL INC, is a renowned platform dedicated to advancing research in the fields of medicine and biomedical sciences. With the ISSN 1947-489X, this journal provides a comprehensive outlet for high-quality original research, reviews, and clinical studies that aim to enhance our understanding of medical practices and biomedical innovations. The journal plays a vital role in disseminating knowledge that bridges the gap between scientific inquiry and practical application, making it essential for researchers, healthcare professionals, and students alike. By maintaining rigorous publication standards and fostering a collaborative academic environment, the Ibnosina Journal remains a cornerstone in supporting the growth and evolution of medical and biomedical sciences worldwide. While it does not currently offer Open Access options, the content continues to serve as a critical resource for enhancing scholarship in the discipline.

Rawal Medical Journal, published by the Pakistan Medical Association, is a prominent academic resource committed to disseminating innovative research in the fields of medicine and nursing. With an ISSN of 0303-5212, this journal serves as a key platform for scholars, practitioners, and students in Pakistan and beyond, contributing to the evolving discourse in healthcare. Although it is currently categorized in the Q4 quartile for both Medicine (miscellaneous) and Nursing (miscellaneous), the journal remains an essential publication for those seeking to enhance their understanding of emerging medical trends and professional practices. Covering research from 2008 to 2024, it aims to foster a collaborative environment for practitioner-oriented and clinical investigations, despite its preliminary ranking in both categories. The journal does not offer Open Access, which invites readers to obtain institutional access or purchase articles directly, ensuring that high-quality research remains accessible to those committed to advancing their knowledge in these vital fields. With its headquarters located at PMA House, Aga Khan III Rd, Karachi, Pakistan, the Rawal Medical Journal is particularly well-situated to address both local and global health challenges.

ANNALS OF MEDICINE, published by Taylor & Francis Ltd, stands as a leading journal in the field of medical research, holding a prestigious Q1 ranking within the miscellaneous medicine category as of 2023. With a focus on disseminating high-quality, peer-reviewed research, the journal provides a vital platform for scholars, clinicians, and policy-makers to share innovative findings that advance the understanding and practice of medicine. Established in 1961, ANNALS OF MEDICINE has continuously evolved, promoting interdisciplinary approaches and fostering collaboration among researchers across various medical specialties. Its impressive Scopus rank of #103 out of 636, representing the top 83rd percentile in general medicine, underscores its influence and importance in the medical community. Although it does not offer Open Access options, the journal remains committed to maintaining rigorous academic standards, making it an essential resource for anyone dedicated to improving healthcare outcomes through scholarly research.

International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.

Frontiers in Medicine, published by FRONTIERS MEDIA SA, is a distinguished open-access journal that has been at the forefront of medical research since its inception in 2014. With an impressive 2023 Q1 ranking in the field of miscellaneous medicine and a notable Scopus rank of #93 out of 636—placing it in the 85th percentile in the general medicine category—this journal serves as a pivotal resource for academics and practitioners. Hailing from Switzerland, Frontiers in Medicine aims to publish high-quality research that addresses the most pressing issues in the medical field, fostering innovation and collaboration among researchers worldwide. By facilitating open access to comprehensive, peer-reviewed articles, the journal enhances the dissemination of knowledge and encourages interdisciplinary dialogues essential for medical advancement. Whether you're a researcher, a clinician, or a student, this journal is an invaluable tool for staying abreast of the latest developments in medicine.

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

Current Medical Science is a prominent academic journal dedicated to advancing knowledge in the fields of Medicine, Biochemistry, and Genetics. Published by SPRINGER with an ISSN of 2096-5230 and E-ISSN 2523-899X, this journal is based in China and serves as a vital resource for researchers, professionals, and students alike. With a focus on innovative research and emerging trends, Current Medical Science has established itself with an impactful presence, operating under Open Access guidelines to ensure wide dissemination of scientific findings. The journal's recognition is underscored by its impressive Scopus rankings, including a Q3 quartile placement in Biochemistry and Genetics as of 2023. It is noteworthy that the journal spans converged years from 2018 to 2024, providing a comprehensive platform for scholarly discussions and developments that drive the evolution of medical science. As it continues to publish influential research, Current Medical Science plays an essential role in bridging the gap between laboratory science and clinical application.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.